Diamond Biofund Inc. Stock

Equities

6901

TW0006901002

Investment Management & Fund Operators

End-of-day quote Taiwan S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
39.7 TWD +2.19% Intraday chart for Diamond Biofund Inc. +2.06% -18.65%
Sales 2022 1.02B 31.29M Sales 2023 -2.44B -75.15M Capitalization 41.45B 1.28B
Net income 2022 798M 24.58M Net income 2023 -2.58B -79.57M EV / Sales 2022 36.8 x
Net cash position 2022 10.73B 331M Net cash position 2023 9.52B 293M EV / Sales 2023 -13.1 x
P/E ratio 2022
62 x
P/E ratio 2023
-14.7 x
Employees 28
Yield 2022
0.26%
Yield 2023
-
Free-Float 16.53%
More Fundamentals * Assessed data
Dynamic Chart
Diamond Biofund Inc. Approves Election of Directors of Board CI
Diamond Biofund Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Diamond Biofund Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Diamond Biofund Inc. Announces Chief Financial Officer Changes CI
Diamond Biofund Inc.(TWSE:6901) added to Taiwan TAIEX Index CI
Diamond Biofund Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Diamond Biofund Inc. has completed an IPO in the amount of TWD 4 billion. CI
Diamond Biofund Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Diamond Biofund Inc. Appoints Patricia Chou as CFO CI
Diamond Biofund Inc. Announces a Cash Dividend, Payable on September 8, 2023 CI
Diamond Biofund Inc. has filed an IPO in the amount of TWD 4 billion. CI
Diamond Biofund Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Diamond Biofund Inc.(TPEX:6901) added to S&P Global BMI Index CI
Ativa Medical Corporation announced that it has received $15 million in funding from Ping An Ventures, Zhejiang Dian Diagnostics Co., Investment Arm, Diamond Biofund Inc., Hermed Capital co.,Ltd, Laboratory Corp. of America Holdings, GIMDx, and other investors. CI
Ativa Medical Corporation announced that it expects to receive $15 million in funding. CI
More news
1 day+2.19%
1 week+2.06%
1 month-2.22%
3 months-13.60%
6 months-21.85%
Current year-18.65%
More quotes
1 week
38.70
Extreme 38.7
40.25
1 month
38.70
Extreme 38.7
41.30
Current year
38.50
Extreme 38.5
49.15
1 year
38.50
Extreme 38.5
77.30
3 years
28.03
Extreme 28.0262
200.19
5 years
28.03
Extreme 28.0262
200.19
10 years
28.03
Extreme 28.0262
200.19
More quotes
Date Price Change Volume
24-05-31 39.7 +2.19% 1,708,515
24-05-30 38.85 -1.15% 447,662
24-05-29 39.3 -1.01% 552,014
24-05-28 39.7 +1.53% 625,769
24-05-27 39.1 +0.51% 635,866

End-of-day quote Taiwan S.E., May 30, 2024

More quotes
Diamond Biofund Inc is a Taiwan-based company primarily engaged in the venture capital and general investment industries. The Company focuses on investments in the biotechnology and medical fields. Main investment areas include new drug research and development, high-end medical devices, innovative medical service technologies or models, medical access, and agricultural biotechnology. The Company's investments are primarily in the domestic sector.
More about the company